CORCEPT THERAPEUTICS INC — Director's Dealing 2011

Oct 25, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2011-10-21

Reporting Person: WHITE JAMES N (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-10-21	Common Stock	J	104550.0000	$0.0000	Acquired	233771.0000	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-10-21	Common Stock Warrant	$2.7700	J	6558.0000	Acquired	2015-03-24	Common Stock (6558.0000)	Indirect
2011-10-21	Common Stock Warrant	$2.7700	J	1015.0000	Acquired	2015-03-24	Common Stock (1015.0000)	Indirect
2011-10-21	Common Stock Warrant	$2.9600	J	5820.0000	Acquired	2013-04-21	Common Stock (5820.0000)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	19086.0000	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Common Stock Warrant	$2.7700	2015-03-24	Common Stock (2039.0000)	2039.0000	Indirect

Footnotes

F1: Distribution of shares without consideration to Managing Directors of the General Partner of Sutter Hill Ventures, A California Limited Partnership, in accordance with the partnership agreement.

F2: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust.

F3: Shares held by SHV Profit Sharing Plan, a retirement trust, for the benefit of the reporting person.